...
search icon
  • Apple, Inc AAPL
  • S&P 500 ETF Trust SPDR SPY
  • Alphabet Inc. - Class A Shares GOOGL
  • Microsoft Corporation MSFT
  • Meta Platforms Inc META
  • Netflix, Inc. NFLX
  • Amazon.com Inc. AMZN
  • Spotify Technology SA SPOT
    bdrx-img

    Biodexa Pharmaceticals, Common Stock

    BDRX

    NAQ

    $1.55

    -$0.01

    (-0.64%)

    1D
    Industry: Biotechnology Sector: Health Care

    Analyst Forecast

    Overview Returns Financials Ratios News FAQs

    Price Chart

    Key Metrics

    Market Cap info-icon
    This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
     $3.54M
    P/E Ratio info-icon
    This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
     0
    Volume info-icon
    This is the total number of shares traded during the most recent trading day.
     152.86K
    Avg Volume info-icon
    This is the average number of shares traded during the most recent 30 days.
     0
    Dividend Yield info-icon
    This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
     0.00%
    Beta info-icon
    This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
     1.71
    52-week Range info-icon
    This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
    $1.14 L
    $74 H
    $1.55

    About Biodexa Pharmaceticals, Common Stock

    Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes. The company is also developing MTX110, which is currently in Phase I studies for the treatment of diffuse intrinsic recurrent glioblastoma, diffuse midline glioma, and medulloblastoma; and MTD217, a program centered around a water-soluble drug formulation that can be easily infused or injected simultaneously, or sequentially, directly into the cancer microenvironment, currently under preclinical studies for the treatment of leptomeningeal disease. In addition, the company offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. It has collaboration agreements with Janssen and Melior. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom. more

    Industry: BiotechnologySector: Health Care

    Returns

    Time FrameBDRXSectorS&P500
    1-Week Return12.32%3.64%6.36%
    1-Month Return-2.52%-5.42%-5.32%
    3-Month Return-64.04%-6.89%-8.86%
    6-Month Return-75.44%-7.54%-5.61%
    1-Year Return-91.45%-1.81%8.61%
    3-Year Return-100%2.1%27.58%
    5-Year Return-100%35.25%90.38%
    10-Year Return-100%88.1%160.03%

    Financials

    Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
    Total Revenue343.00K578.00K699.00K381.00K-[{"date":"2020-12-31","value":49.07,"profit":true},{"date":"2021-12-31","value":82.69,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":54.51,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Cost of Revenue6.07M4.65M5.11M4.07M5.44M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":76.7,"profit":true},{"date":"2022-12-31","value":84.23,"profit":true},{"date":"2023-12-31","value":67.02,"profit":true},{"date":"2024-12-31","value":89.6,"profit":true}]
    Gross Profit(5.72M)(4.08M)(4.41M)(3.69M)(5.44M)[{"date":"2020-12-31","value":-572500000,"profit":false},{"date":"2021-12-31","value":-407600000,"profit":false},{"date":"2022-12-31","value":-441200000,"profit":false},{"date":"2023-12-31","value":-368600000,"profit":false},{"date":"2024-12-31","value":-543700000,"profit":false}]
    Gross Margin(1669.10%)(705.19%)(631.19%)(967.45%)(Infinity%)[{"date":"2020-12-31","value":-1669.1,"profit":false},{"date":"2021-12-31","value":-705.19,"profit":false},{"date":"2022-12-31","value":-631.19,"profit":false},{"date":"2023-12-31","value":-967.45,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
    Operating Expenses17.71M1.99M4.05M4.33M9.20M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":11.21,"profit":true},{"date":"2022-12-31","value":22.88,"profit":true},{"date":"2023-12-31","value":24.44,"profit":true},{"date":"2024-12-31","value":51.94,"profit":true}]
    Operating Income(10.67M)(7.00M)(8.93M)(8.01M)(9.20M)[{"date":"2020-12-31","value":-1067100000,"profit":false},{"date":"2021-12-31","value":-699800000,"profit":false},{"date":"2022-12-31","value":-893200000,"profit":false},{"date":"2023-12-31","value":-801400000,"profit":false},{"date":"2024-12-31","value":-919900000,"profit":false}]
    Total Non-Operating Income/Expense(463.00K)848.00K420.00K571.00K3.22M[{"date":"2020-12-31","value":-14.38,"profit":false},{"date":"2021-12-31","value":26.34,"profit":true},{"date":"2022-12-31","value":13.04,"profit":true},{"date":"2023-12-31","value":17.73,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
    Pre-Tax Income(23.47M)(6.11M)(8.49M)(7.49M)(5.98M)[{"date":"2020-12-31","value":-2347000000,"profit":false},{"date":"2021-12-31","value":-610600000,"profit":false},{"date":"2022-12-31","value":-848800000,"profit":false},{"date":"2023-12-31","value":-748500000,"profit":false},{"date":"2024-12-31","value":-597900000,"profit":false}]
    Income Taxes1.28M646.00K832.00K(406.00K)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":50.43,"profit":true},{"date":"2022-12-31","value":64.95,"profit":true},{"date":"2023-12-31","value":-31.69,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
    Income After Taxes(24.75M)(6.75M)(9.32M)(7.08M)-[{"date":"2020-12-31","value":-2475100000,"profit":false},{"date":"2021-12-31","value":-675200000,"profit":false},{"date":"2022-12-31","value":-932000000,"profit":false},{"date":"2023-12-31","value":-707900000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
    Income From Continuous Operations(22.19M)(5.46M)(7.66M)(7.08M)(5.73M)[{"date":"2020-12-31","value":-2218900000,"profit":false},{"date":"2021-12-31","value":-546000000,"profit":false},{"date":"2022-12-31","value":-765600000,"profit":false},{"date":"2023-12-31","value":-707900000,"profit":false},{"date":"2024-12-31","value":-572900000,"profit":false}]
    Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Net Income(22.19M)(5.46M)(7.66M)(7.08M)(5.73M)[{"date":"2020-12-31","value":-2218900000,"profit":false},{"date":"2021-12-31","value":-546000000,"profit":false},{"date":"2022-12-31","value":-765600000,"profit":false},{"date":"2023-12-31","value":-707900000,"profit":false},{"date":"2024-12-31","value":-572900000,"profit":false}]
    EPS (Diluted)-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

    Ratios

    Liquidity

    These ratios help you determine the liquidity of the company. Higher is better.

    BDRX
    Cash Ratio 0.33
    Current Ratio 1.75

    Asset Efficiency

    These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

    BDRX
    ROA (LTM) -45.41%
    ROE (LTM) -88.14%

    Liabilities

    These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

    BDRX
    Debt Ratio Lower is generally better. Negative is bad. 0.44
    Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.56

    Valuation

    These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

    BDRX
    Trailing PE NM
    Forward PE NM
    P/S (TTM) 0.58
    P/B 0.36
    Price/FCF NM
    EV/R 4.70
    EV/Ebitda 0.03

    Discover more

    Tsla

    Tesla, Inc.
    aaple

    Apple, Inc.
    GOOGL

    Alphabet Inc. - Class A Shares
    META

    Meta Platforms Inc
    AMZN

    Amazon.com Inc.
    Microsoft

    Microsoft Corporation
    NVDA

    NVIDIA Corporation
    BRK

    Berkshire Hathaway Inc. Hld B
    LLY

    Eli Lilly and Company

    FAQs

    What is Biodexa Pharmaceticals share price today?

    Biodexa Pharmaceticals (BDRX) share price today is $1.55

    Can Indians buy Biodexa Pharmaceticals shares?

    Yes, Indians can buy shares of Biodexa Pharmaceticals (BDRX) on Vested. To buy Biodexa Pharmaceticals from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BDRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

    Can Fractional shares of Biodexa Pharmaceticals be purchased?

    Yes, you can purchase fractional shares of Biodexa Pharmaceticals (BDRX) via the Vested app. You can start investing in Biodexa Pharmaceticals (BDRX) with a minimum investment of $1.

    How to invest in Biodexa Pharmaceticals shares from India?

    You can invest in shares of Biodexa Pharmaceticals (BDRX) via Vested in three simple steps:

    • Click on Sign Up or Invest in BDRX stock at the top of this page
    • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
    • Transfer USD funds to your US Brokerage account and start investing in Biodexa Pharmaceticals shares
    What is Biodexa Pharmaceticals 52-week high and low stock price?

    The 52-week high price of Biodexa Pharmaceticals (BDRX) is $74. The 52-week low price of Biodexa Pharmaceticals (BDRX) is $1.14.

    What is Biodexa Pharmaceticals price-to-book (P/B) ratio?

    The price-to-book (P/B) ratio of Biodexa Pharmaceticals (BDRX) is 0.36

    What is the Market Cap of Biodexa Pharmaceticals?

    The market capitalization of Biodexa Pharmaceticals (BDRX) is $3.54M

    What is Biodexa Pharmaceticals’s stock symbol?

    The stock symbol (or ticker) of Biodexa Pharmaceticals is BDRX

    Feedback

    Signup to access all features and start your US investing journey!

    • Open your account in minutes
    • Take your portfolio global, starting at just $1
    Get started

    Add ticker to compare

    Scroll to Top